Effects of over-expression of SOD2 in bone marrow-derived mesenchymal stem cells on traumatic brain injury
Intravenous administration of bone marrow-derived mesenchymal stem cells (BM-MSCs) has been shown to promote nerve cell regeneration following traumatic brain injury (TBI). As the anti-oxidant defense systems in neuronal tissue including superoxide dismutase 2 (SOD2) are crucial to defend cell against oxidative stress. We proposed a new stratege to increase the therapeutic effect of MSCs by preventing cells death from oxidative stress. We overexpressed SOD2 in BM-MSCs, transplanted these MSCs into TBI model mice, assessed the protective effect of SOD2 against oxidation-induced apoptosis in BM-MSCs both in vitro and in vivo, evaluated brain functional recovery by the rotarod behavioral test, and tested the oxidation status of TBI mice brain after BM-MSCs transplantation by monitoring the superoxide dismutase, glutathione and malonaldehyde level. We found over-expression of SOD2 protected BM-MSCs from H2O2-induced cell apoptosis. Injection of SOD2 over-expressed BM-MSCs attenuated neuro-inflammation in the ipsilateral cortex of TBI mice, and protected TBI mice against loss of blood–brain barrier integrity. Furthermore, the rotarod behavioral test showed functional recovery of TBI mice after MSC treatment. Our experiments indicated that SOD2-over-expressed BM-MSCs have an improved therapeutic effect on brain injury treatment in TBI mice.
KeywordsTraumatic brain injury (TBI) Mesenchymal stem cell (MSC) Superoxide dismutase 2 (SOD2) Oxidative stress Antioxidant
Compliance with ethical standards
Disclosure of potential conflicts of interest
The authors declare that they have no conflict of interest.
- Daneshvar DH, Riley DO, Nowinski CJ, McKee AC, Stern RA, Cantu RC (2011) Long-term consequences: effects on normal development profile after concussion. Phys Med Rehabil Clin N Am 22(683–700):ixGoogle Scholar
- Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317CrossRefPubMedGoogle Scholar
- Gavioli M, Luppi G, Losi L, Bertolini F, Santantonio M, Falchi AM, D'Amico R, Conte PF, Natalini G (2005) Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer. Dis Colon Rectum 48:1851–1857CrossRefPubMedGoogle Scholar
- Meseguer-Olmo L, Montellano AJ, Martinez T, Martinez CM, Revilla-Nuin B, Roldan M, Mora CF, Lopez-Lucas MD, Fuente T (2017) Intraarticular and intravenous administration of 99MTc-HMPAO-labeled human mesenchymal stem cells (99MTC-AH-MSCS): in vivo imaging and biodistribution. Nucl Med Biol 46:36–42CrossRefPubMedGoogle Scholar
- Moghadasali R, Mutsaers HA, Azarnia M, Aghdami N, Baharvand H, Torensma R, Wilmer MJ, Masereeuw R (2013) Mesenchymal stem cell-conditioned medium accelerates regeneration of human renal proximal tubule epithelial cells after gentamicin toxicity. Exp Toxicol Pathol 65:595–600CrossRefPubMedGoogle Scholar
- Nargesi AA, Lerman LO, Eirin A (2017) Mesenchymal stem cell-derived extracellular vesicles for renal repair. Curr Gene Ther 17:29–42Google Scholar
- Rooney GE, Moran C, McMahon SS, Ritter T, Maenz M, Flugel A, Dockery P, O'Brien T, Howard L, Windebank AJ, Barry FP (2008) Gene-modified mesenchymal stem cells express functionally active nerve growth factor on an engineered poly lactic glycolic acid (PLGA) substrate. Tissue Eng Part A 14:681–690CrossRefPubMedGoogle Scholar
- Sevivas N, Teixeira FG, Portugal R, Araujo L, Carrico LF, Ferreira N, Vieira da Silva M, Espregueira-Mendes J, Anjo S, Manadas B, Sousa N, Salgado AJ (2017) Mesenchymal Stem Cell Secretome: A Potential Tool for the Prevention of Muscle Degenerative Changes Associated With Chronic Rotator Cuff Tears. Am J Sports Med 45:179–188Google Scholar
- Tseng WL, Chou SJ, Chiang HC, Wang ML, Chien CS, Chen KH, Leu HB, Wang CY, Chang YL, Liu YY, Jong YJ, Lin SZ, Chiou SH, Lin SJ, Yu WC (2017) Imbalanced production of reactive oxygen species and mitochondrial antioxidant SOD2 in Fabry disease-specific human induced Pluripotent stem cell-differentiated vascular endothelial cells. Cell Transplant 26:513–527CrossRefPubMedPubMedCentralGoogle Scholar
- Zhao Y, Gibb SL, Zhao J, Moore AN, Hylin MJ, Menge T, Xue H, Baimukanova G, Potter D, Johnson EM, Holcomb JB, Cox CS Jr, Dash PK, Pati S (2016) Wnt3a, a protein secreted by Mesenchymal stem cells is Neuroprotective and promotes Neurocognitive recovery following traumatic brain injury. Stem Cells 34:1263–1272CrossRefPubMedGoogle Scholar